New product : Chophyshot®
Chophyshot®, your solution to take during periods of overeating
Chophyshot® is an artichoke-based dietary supplement with sweeteners to be taken during periods of festive overindulgence.
Thanks to its compact size containing a single daily dose, you can easily take this 10-ml bottle with you wherever you go.
Chophyshot® has been developed by our Research and Development teams in Chatou. Made from artichoke (11%), it is sugar-free and has an orange and grapefruit flavour.
Chophyshot® should be taken once a day during periods of overeating.
Chophyshot® will be available in pharmacies from October 2016.
Recommended Retail Price: €1.50
Alcohol 2.6% vol.
Chophyshot® is a dietary supplement to be taken during periods of overeating. This product should not be used as a substitute for a varied diet.
Eat at least five portions of fruit and vegetables a day to stay healthy. http://www.mangerbouger.fr
Chophyshot® must not be used by pregnant or breastfeeding women.
It is not advisable to exceed the recommended daily dose (a single daily dose).
INFORMATION
Please be informed that Mayoly Spindler has no office in Australia.
If you have been contacted or have been proposed a job by a person who identified him/herself as an employee of Mayoly Australia, using an email address with @mayolyspindlerpharma.net, you are victim of a fraud.
Mayoly Spindler will not accept any liability in the case you would accept or have accepted the job offered in the context of this fraud.
Mayoly Spindler is involved in research on Irritable Bowel Syndrome as a partner of the French Neuro-Gastroenterology Group (GFNG). Like every year, we are participating in the GFNG Annual Meeting at the Embarcadère in Lyon on 25 and 26 June. Please come visit us at our booth where we will be happy to welcome you.
For more information: gfng-2015-lyon
The French Neuro-Gastroenterology Group (GFNG) combines clinical and basic research units interested in the mechanisms and treatment of functional disorders associated with digestive pain and discomfort.
The GFNG General Meeting was held this year on 25 and 26 June in Lyon, and brought together a hundred participants including 9 national and international speakers (Swedish, Spanish, Swiss). The delegates were able discuss various issues with the speakers at the scientific sessions, in particular Irritable Bowel Syndrome. Presentation topics included visceral hypersensitivity, inflammation of mucous membranes and abdominal bloating.
Like every year, Mayoly Spindler was present at the meeting to support gastroenterologists and their research.
The Francophone Forum for Hepato-Gastroenterology and Digestive Oncology (JFHOD) took place from March 19 to 22 at the Paris Convention Centre.
JFHOD 2015 was exceptionally busy with over 3770 participants and 55 industrial and institutional partners.
The country in the spotlight was Algeria and the main theme was genetics.
All our French-Algerian teams took turns staffing our booth to speak with the gastroenterologists.
Our two lunch workshops were a great success, with nearly 700 doctors attending.
An article will be published in the Gastroenterology newsletter that Mayoly Spindler sponsors and in the journal Hépato-Gastro & Oncologie Digestive.
Our Franco-Algerian Symposium brought together 54 Algerian gastroenterologists on the theme: Helicobacter pylori infection: "Commonalities and specificities in France and Algeria."
JFHOD is THE conference of the year for gastroenterology for Mayoly Spindler. We were able to make our mark at the 2015 Forum and emerge as an essential partner for gastroenterologists.
Mayoly Spindler participated in the 9th Congress of General Practice France which took place from 26 to 28 March 2015 at the Paris Convention Centre.
This congress, organized by the College of General Medicine, attracted 4000 participants this year, including 72 industrial partners.
At the Congress, general practitioners can learn about and discuss the issues they encounter in their daily practice.
Mayoly Spindler is a partner of the Francophone Forum of Hepato-Gastroenterology and Digestive Oncology 2015. Visit our booth and our 2 workshops lunches: "Optimizing colonoscopy in 2015: for whom, how, based on what criteria and how far?" and "Cholestatic diseases and ursodeoxycholic acid: current practices."
For more information : www.jfhod.com/.